Literature DB >> 32084630

Responsiveness of standard spine outcome tools: do they measure up?

Carolyn E Schwartz1,2,3, Roland B Stark1, Phumeena Balasuberamaniam4, Mopina Shrikumar4, Abeer Wasim4, Joel A Finkelstein4,5.   

Abstract

OBJECTIVE: Over the past 2 decades, spine outcome research has become more standardized in response to recommendations from Deyo and others. By using the same generic and condition-specific patient-reported outcome (PRO) measures across studies, results are more easily compared. Given the challenges of maintaining high-quality data in clinical research studies, it would be important to evaluate the contribution of each PRO to confirm that it merits the respondent burden. This study aimed to examine the spine PROs' association with clinically important change and relative responsiveness in explaining variance in patients' global assessment of change (GAC).
METHODS: This prospective longitudinal cohort study included adults recruited from 4 active spine surgery practices at a Toronto-based hospital. Patients were diagnosed with a degenerative lumbar spinal condition and underwent spinal decompression and/or fusion surgery. Participants completed the RAND-36 (to generate the physical component score [PCS] and mental component score [MCS]), Oswestry Disability Index (ODI), the numeric rating scale (NRS) for pain, Patient-Reported Outcomes Measurement Information System (PROMIS) pain interference, and a GAC item. Random-effects models were used to investigate the sensitivity of PROs to the GAC and their responsiveness over time (i.e., PRO main effects and PRO-by-time interactions, respectively).
RESULTS: The study sample included 168 patients (mean age 61 years, 50% female) with preoperative and up to 12 months of postoperative data. Random-effects models revealed significant main effects for all PROs. Significant time-by-PRO interactions were detected for the PCS, PROMIS, ODI, and NRS (p < 0.0005 in all cases), but not for the MCS. Further examination revealed different sensitivity of the PROs to the GAC at different times. The NRS, PROMIS, and PCS showed higher sensitivity early after surgery, and the PCS evinced a marked drop in sensitivity to the GAC at about 8 months postsurgery.
CONCLUSIONS: All PROs currently included in the spine outcome core measures are associated with patients' subjective assessment of a clinically important change, and all but the MCS scores are responsive to such change. Based on these findings, the core spine PROs could be reduced to include fewer estimates of pain. The authors suggest replacing the less responsive measures with tools that help to characterize factors that are driving the patients' subjective assessment of change and that meaningfully address some of the higher levels in the hierarchy of quality-of-life outcomes.

Entities:  

Keywords:  GAC = global assessment of change; HIPAA = Health Information Portability and Accountability Act; MCS = mental component score; NRS = numeric rating scale; ODI = Oswestry Disability Index; PCS = physical component score; PRO = patient-reported outcome; PROMIS = Patient-Reported Outcomes Measurement Information System; patient-reported outcomes; quality of life; redundancy; responsiveness; spine

Year:  2020        PMID: 32084630     DOI: 10.3171/2019.12.SPINE191367

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  2 in total

1.  Can artificial intelligence support or even replace physicians in measuring sagittal balance? A validation study on preoperative and postoperative full spine images of 170 patients.

Authors:  Priyanka Grover; Jakob Siebenwirth; Christina Caspari; Steffen Drange; Marcel Dreischarf; Jean-Charles Le Huec; Michael Putzier; Jörg Franke
Journal:  Eur Spine J       Date:  2022-07-07       Impact factor: 2.721

Review 2.  Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection.

Authors:  Olalekan Lee Aiyegbusi; Jessica Roydhouse; Samantha Cruz Rivera; Paul Kamudoni; Peter Schache; Roger Wilson; Richard Stephens; Melanie Calvert
Journal:  Nat Commun       Date:  2022-10-12       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.